tiprankstipranks
China Innovation Investment Limited (HK:1217)
:1217
Hong Kong Market
Want to see HK:1217 full AI Analyst Report?

China Innovation Investment Limited (1217) AI Stock Analysis

0 Followers

Top Page

HK:1217

China Innovation Investment Limited

(1217)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
HK$0.01
▲(20.00% Upside)
Action:Reiterated
Date:06/27/26
The score is primarily supported by a very strong, low-leverage balance sheet and a rebound in reported profitability, but it is held back by weak earnings-to-cash conversion (negative 2025 operating cash flow) and neutral-to-weak technical momentum (below the 200-day average with a slightly negative MACD). Low valuation (P/E 2.5) provides a positive offset.
Positive Factors
Extremely Low Leverage
Minimal debt reduces interest burden and refinancing risk, giving the company financial resilience through weaker operating periods. The large equity base also provides flexibility to sustain operations or fund opportunities without relying heavily on external borrowing.
Negative Factors
Negative Operating Cash Flow
The reversal from strong operating cash flow in 2023–2024 to a negative 2025 result indicates that reported earnings are not currently converting reliably into cash. Persistent weak conversion could constrain reinvestment, distributions, and the durability of reported profits.
Read all positive and negative factors
Positive Factors
Negative Factors
Extremely Low Leverage
Minimal debt reduces interest burden and refinancing risk, giving the company financial resilience through weaker operating periods. The large equity base also provides flexibility to sustain operations or fund opportunities without relying heavily on external borrowing.
Read all positive factors

China Innovation Investment Limited (1217) vs. iShares MSCI Hong Kong ETF (EWH)

China Innovation Investment Limited Business Overview & Revenue Model

Company Description
China Innovation Investment Limited invests in equity-related securities and debt instruments in listed and unlisted companies in Hong Kong and the People’s Republic of China. It also engages in transactions comprising options and futures that are...
How the Company Makes Money
null...

China Innovation Investment Limited Financial Statement Overview

Summary
Strong balance sheet with extremely low leverage (Balance Sheet Score: 88) supports resilience. Profitability rebounded with sharp 2025 revenue growth and high reported margins (Income Statement Score: 74), but results appear volatile across years. The main weakness is cash quality: operating cash flow turned negative in 2025 and free cash flow fell to zero after stronger 2023–2024 periods (Cash Flow Score: 45).
Income Statement
74
Positive
Balance Sheet
88
Very Positive
Cash Flow
45
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue-9.25M64.56M20.26M3.12M34.38M-26.73M
Gross Profit-11.23M62.55M20.26M9.53M12.16M-27.62M
EBITDA-26.96M57.65M5.91M3.24M6.64M-32.94M
Net Income-27.94M56.67M5.00M2.19M5.76M-34.01M
Balance Sheet
Total Assets639.85M703.09M548.58M550.22M564.03M612.68M
Cash, Cash Equivalents and Short-Term Investments248.43M274.77M299.84M177.96M137.63M156.54M
Total Debt0.00474.00K1.38M2.23M475.00K1.39M
Total Liabilities100.46M102.17M5.87M2.55M770.00K1.68M
Stockholders Equity539.38M600.92M542.71M547.67M563.26M611.00M
Cash Flow
Free Cash Flow21.64M-29.64M178.84M28.56M-15.37M-19.35M
Operating Cash Flow-16.16M-37.80M178.84M28.62M-14.95M-19.35M
Investing Cash Flow-34.05M-50.00M-4.97M6.18M9.14M16.79M
Financing Cash Flow-934.00K-907.00K-854.00K-883.00K-915.00K-871.00K

China Innovation Investment Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.01
Price Trends
50DMA
0.01
Negative
100DMA
0.01
Negative
200DMA
0.01
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
48.11
Neutral
STOCH
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1217, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.11 is Neutral, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1217.

China Innovation Investment Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
64
Neutral
HK$128.02M-4.55-4.90%-126.01%-237.50%
62
Neutral
HK$1.98B0.1946.43%2.46%-20.87%9155.74%
55
Neutral
HK$328.01M2.3346.99%1098.58%
45
Neutral
HK$691.21M-6.10-33.51%10.29%-257.25%
43
Neutral
HK$523.08M-1.12-63.18%0.09%
41
Neutral
HK$22.41M-0.02-62.39%-26.78%-166.41%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1217
China Innovation Investment Limited
0.01
>-0.01
-33.33%
HK:0204
China Investment Development Limited
0.09
-0.93
-91.18%
HK:1140
Wealthking Investments Limited
0.11
<0.01
5.77%
HK:1226
China Investment and Finance Group Ltd
0.80
0.02
1.92%
HK:0612
China Investment Fund Company Limited
0.34
0.00
0.00%
HK:0080
China New Economy Fund Ltd.
0.26
-0.18
-40.50%

China Innovation Investment Limited Corporate Events

China Innovation Investment Reports Unaudited NAV Per Share of HK$0.044
Aug 12, 2026
China Innovation Investment Limited has disclosed that its unaudited net asset value per share stood at approximately HK$0.044 as of 31 July 2026. The update provides investors with a snapshot of the company&#8217;s asset backing per share, offeri...
China Innovation Investment Sets Board Meeting to Review Interim Results and Dividend
Aug 10, 2026
China Innovation Investment Limited has scheduled a board meeting in Hong Kong on 24 August 2026 to review and approve its unaudited interim results for the six months ended 30 June 2026. The board will also consider the potential declaration of a...
China Innovation Investment Reports HK$0.042 Unaudited NAV Per Share
Jul 14, 2026
China Innovation Investment Limited reported that its unaudited net asset value per share stood at approximately HK$0.042 as of 30 June 2026. The disclosure provides investors with an updated snapshot of the company&#8217;s balance-sheet strength ...
China Innovation Investment warns of HK$61 million interim loss on Hong Kong market volatility
Jul 14, 2026
China Innovation Investment Limited has warned that it expects to swing to a loss of about HK$61 million for the six months ended 30 June 2026, compared with a profit of approximately HK$23 million a year earlier. The deterioration is mainly attri...
China Innovation Investment Announces Unaudited Net Asset Value Per Share
Jun 11, 2026
China Innovation Investment Limited reported that its unaudited net asset value per share stood at approximately HK$0.045 as of 31 May 2026, providing investors with an updated snapshot of the company&#8217;s underlying asset base. The disclosure,...
China Innovation Investment Wins Unanimous Backing at 2025 AGM
May 29, 2026
China Innovation Investment Limited reported that all resolutions at its 2025 annual general meeting, held on 29 May 2026, were approved by shareholders via poll, with more than 3.8 billion shares voting and 100% support for each motion. The meeti...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 27, 2026